Cell based therapy is gaining momentum : Dr Pradeep V Mahajan – ETHealthworld.com

Posted: Published on August 26th, 2017

This post was added by Dr P. Richardson

Recently Dr Pradeep V Mahajan was honoured with Paris Appreciation Awards, 2017 for Excellence in stem cell therapy. He is the Chairman and Managing Director of StemRx Bioscience Solutions Pvt Ltd. In an interview with ETHealthworld, Dr Mahajan talks about the latest advancements in stem cell therapy and where it stands in healthcare system today. Edited excerpts :

How well informed are the doctors today about the cellular therapy? Is it time consuming? Where does cellular therapy stand in the Indian Healthcare system today?

For more than four decades, medical fraternity has knowledge about stem cell science and its potential therapeutic applications. However, earlier, clinicians were commonly aware of hematopoietic stem cell therapy, but were relatively uninformed about the advantages of mesenchymal stem cells. This could be attributed to the medical course syllabus which initially did not include topics specifically on cellular therapy.

Despite the technological advances that medical science is witnessing, it is not possible at present to predict the exact time when cellular therapy and regenerative medicine will replace existing forms of pharmacological and surgical treatments. Nonetheless, there is increasing awareness amongst clinicians who now more receptive to and are advising cell based therapy as an effective therapeutic modality for treatment of diseases.

Which are the diseases that can be treated through cellular therapy? What are the latest advancements?

Cellular therapy and regenerative medicine focuses on eliminating the root cause of the problem by use of cells (cytokines, chemokines etc.), growth factors from ones own body. Orthopedic conditions such as avascular necrosis, osteoarthritis, autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, neurological conditions such as cerebral palsy, stroke etc., as well as diabetes, liver, genitourinary disorders, dermatological conditions and many more can achieve benefits from cellular therapy. This form of therapy can be further explored in management of organ failure, to overcome rejection following organ transplants, developmental defects, cancer immunotherapy etc.

Research advances pertaining to introducing products with cell and scaffold based technology through tissue engineering are underway. Bioactive scaffolds that are capable of supporting activation and differentiation of host stem cells at the required site are being developed. In the future it will be possible to use human native sites as micro-niche/micro-environment for potentiation of the human body's site-specific response.

Technologically, advances have been made over the years in both diagnostic and therapeutic approaches. Molecular imaging technology (optical imaging, positron emission tomography etc.) has simplified research on disease mechanism and treatment evaluation related to cell based therapy. Several new technologies are being introduced that simplify the process of isolation and characterization of cells. One such example is the Prodigy technology which completely automates the procedure of cell manufacturing from start to finish, thus enabling standardization and GMP compliance. In addition, detection and identification of specific cell populations is now possible through gene labeling techniques. Similarly, advances in microscopy have enabled study of cell behavior with respect to their surroundings.

What is the scope of cellular therapy in the country?

India is a nation with increasing population demands. Our country is seeing an alarmingly rapid rise in occurrence of diseases and conventional treatment modalities are gradually losing potential to cure affected individuals. Being a developing economy, the application and opportunity of cellular therapy and regenerative medicine is different when compared to other countries. A number game exists between diseases (such as cancer, lifestyle related, autoimmune conditions etc.) and finances in our country. The aim of cellular therapy is to enable a diseased person to use his own body cells for treatment thereby addressing the issue of extreme financial burden as seen with conventional treatment modalities. This will drastically benefit our patients and country and will also propagate India towards becoming the leader in cellular therapy and regenerative medicine.

Follow this link:
Cell based therapy is gaining momentum : Dr Pradeep V Mahajan - ETHealthworld.com

Related Posts
This entry was posted in Cell Therapy. Bookmark the permalink.

Comments are closed.